Rapid delivery of toxicological material
Drug Target Review
SEPTEMBER 10, 2024
However, developing an accelerated IND application requires that good laboratory practice (GLP) toxicological data must be generated, collected, interpreted and integrated in the IND-enabling data package. FDA no longer has to require animal testing for new drugs. References: 1 Wadman M.
65 
Let's personalize your content